Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALGEV - FR0000033888 - Common Stock

178 EUR
0 (0%)
Last: 12/15/2025, 7:00:00 PM
Fundamental Rating

4

ALGEV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 113 industry peers in the Machinery industry. No worries on liquidiy or solvency for ALGEV as it has an excellent financial health rating, but there are worries on the profitability. ALGEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALGEV had positive earnings in the past year.
In the past year ALGEV had a positive cash flow from operations.
In the past 5 years ALGEV has always been profitable.
Of the past 5 years ALGEV 4 years had a positive operating cash flow.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of ALGEV (1.21%) is worse than 69.03% of its industry peers.
With a Return On Equity value of 1.52%, ALGEV is not doing good in the industry: 70.80% of the companies in the same industry are doing better.
ALGEV has a Return On Invested Capital of 0.76%. This is in the lower half of the industry: ALGEV underperforms 79.65% of its industry peers.
ALGEV had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 8.69%.
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROIC 0.76%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

With a Profit Margin value of 2.38%, ALGEV is not doing good in the industry: 60.18% of the companies in the same industry are doing better.
ALGEV's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 1.68%, ALGEV is doing worse than 77.88% of the companies in the same industry.
In the last couple of years the Operating Margin of ALGEV has declined.
Looking at the Gross Margin, with a value of 63.62%, ALGEV belongs to the top of the industry, outperforming 88.50% of the companies in the same industry.
ALGEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

ALGEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ALGEV has less shares outstanding than it did 1 year ago.
ALGEV has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALGEV is higher compared to a year ago.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ALGEV has an Altman-Z score of 3.68. This indicates that ALGEV is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.68, ALGEV is doing good in the industry, outperforming 77.88% of the companies in the same industry.
ALGEV has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALGEV (0.03) is better than 89.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.68
ROIC/WACC0.1
WACC7.85%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 5.18 indicates that ALGEV has no problem at all paying its short term obligations.
ALGEV has a better Current ratio (5.18) than 96.46% of its industry peers.
A Quick Ratio of 3.79 indicates that ALGEV has no problem at all paying its short term obligations.
The Quick ratio of ALGEV (3.79) is better than 96.46% of its industry peers.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 3.79
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

ALGEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.89%.
Measured over the past years, ALGEV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.19% on average per year.
ALGEV shows a small growth in Revenue. In the last year, the Revenue has grown by 2.81%.
The Revenue has been growing slightly by 5.90% on average over the past years.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 395.56, ALGEV can be considered very expensive at the moment.
ALGEV's Price/Earnings ratio is a bit more expensive when compared to the industry. ALGEV is more expensive than 73.45% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.43. ALGEV is valued rather expensively when compared to this.
ALGEV is valuated correctly with a Price/Forward Earnings ratio of 13.15.
ALGEV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALGEV is cheaper than 65.49% of the companies in the same industry.
ALGEV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.66.
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

60.18% of the companies in the same industry are cheaper than ALGEV, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.22
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)111.49
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALGEV has a Yearly Dividend Yield of 2.79%.
Compared to an average industry Dividend Yield of 1.58, ALGEV pays a better dividend. On top of this ALGEV pays more dividend than 84.07% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, ALGEV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

On average, the dividend of ALGEV grows each year by 21.15%, which is quite nice.
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

ALGEV pays out 117.62% of its income as dividend. This is not a sustainable payout ratio.
ALGEV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP117.62%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (12/15/2025, 7:00:00 PM)

178

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30 2025-10-30
Earnings (Next)N/A N/A
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap133.50M
Revenue(TTM)148.53M
Net Income(TTM)3.29M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP117.62%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
P/S 0.97
P/FCF N/A
P/OCF 30.9
P/B 0.62
P/tB 0.63
EV/EBITDA 13.22
EPS(TTM)0.45
EY0.25%
EPS(NY)13.53
Fwd EY7.6%
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)5.76
OCFY3.24%
SpS184.19
BVpS288.75
TBVpS284.6
PEG (NY)111.49
PEG (5Y)N/A
Graham Number54.07
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROCE 1%
ROIC 0.76%
ROICexc 0.85%
ROICexgc 0.87%
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
FCFM N/A
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.85
Cap/Depr 107.05%
Cap/Sales 5.14%
Interest Coverage 250
Cash Conversion 48.26%
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 3.79
Altman-Z 3.68
F-Score6
WACC7.85%
ROIC/WACC0.1
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.83%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.26%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


How profitable is GEVELOT SA (ALGEV.PA) stock?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALGEV stock?

The financial health rating of GEVELOT SA (ALGEV.PA) is 7 / 10.


What is the expected EPS growth for GEVELOT SA (ALGEV.PA) stock?

The Earnings per Share (EPS) of GEVELOT SA (ALGEV.PA) is expected to grow by 3.55% in the next year.